556. Impediments to treatment for Tuberculosis and HIV co-infected patients in a single center in Delhi, India in 2014
Session: Poster Abstract Session: Tuberculosis Treatment and Outcome
Thursday, October 27, 2016
Room: Poster Hall
Posters
  • 556 Choi.pdf (628.3 kB)
  • Background:

    Tuberculosis (TB) is one of the most important opportunistic infections in HIV-positive patients and reported to cause one third of deaths in HIV-positive people in 2014. Initiation of ART (Anti-retroviral therapy) and anti-tuberculosis medications (ATT) are known to reduce mortality. The study is to evaluate the obstacles to treatment in Delhi, India.

    Methods:

    The study is a retrospective chart review of HIV positive patients with active TB registered at the National Institute of TB and Respiratory Diseases Center in Delhi, India in 2014. Patients eligible for inclusion had to be 15 years of age or older, and must have clinical or laboratory diagnosis of active TB and started on anti-tuberculosis treatment in 2014. The outcomes were compared only in patients who started anti-Tb treatment prior to ART. Groups were primarily compared based on outcomes, as well as site of TB infection. Outcome groups were based on WHO definitions, and the completed treatment and cure groups were combined and compared to defaulted and/or deceased group. Univariate analyses were performed using Fisher’s two tailed exact test.

    Results:

    Among 234 patients who were newly registered at the ART clinic, 81 patients (34.6%) had TB and HIV co-infection. 23 patients had pulmonary TB (PTB) and 58 patients had extra-pulmonary TB (EPTB). 7 died in the PTB and 12 died in the EPTB group. Patients who died with PTB had the lowest baseline CD 4 count (79). Interval between initiation of ATT and ART did not affect the outcome of the PTB group but the interval was shorter in the deceased EPTB group than in the completed/cured group (9 vs 23 days). When the completed/cured group (PTB and EPTB combined) was compared to the defaulted group, baseline CD4 count (155.1 vs 153.5), and mean days from ATT to ART initiation (26 vs 25 days) were similar. 66% of the total completed/cured group had secondary school or higher education, and only 23% in the defaulted/deceased group (p=0.013).

    Conclusion:

    The outcome of PTB and EPTB were similar in the completed/cured (52 vs 59%), defaulted (8 vs 10%) and deceased (28 vs 21%) group. Interval days from ATT to ART did not reveal significant difference in outcomes. Education level between completed/cured vs defaulted/deceased groups were significant, perhaps indicating disparities in access.

    Woo Jeong Choi, M.D, Infectious Diseases, Henry Ford Health System, Detroit, MI, David Peter, MD, None, None, MI and Upasna Agarwal, MD, national institute of tuberculosis and respiratory diseases, New Delhi, MI

    Disclosures:

    W. J. Choi, None

    D. Peter, None

    U. Agarwal, None

    Previous Abstract | Next Abstract >>

    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.